Traws Pharma, Inc. — Director's Dealing 2020

Nov 30, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2020-11-25

Reporting Person: Guerin Mark Patrick (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-25	Common Stock	P	16755	$0.26	Acquired	125599	Direct
2020-11-27	Common Stock	P	4614	$0.26	Acquired	130213	Direct